GSAC Relative Valuation - Gelstat Corp

Watchlist Manager

Watchlist

Price: 0.0003 USD

Market Cap: $1.1m

	Gelstat Corp OTC:GSAC	US
	Khaitan Chemicals and Fertilizers Ltd NSE:KHAICHEM	IN
	Jiangsu Transimage Technology Co Ltd SZSE:002866	CN
	Carrefour SA OTC:CRRFY	FR
M	Minshang Creative Technology Holdings Ltd HKEX:1632	HK
	Lammhults Design Group AB STO:LAMM B	SE
	Plug Power Inc NASDAQ:PLUG	US
	Copa Holdings SA NYSE:CPA	PA
	Herige SA PAR:ALHRG	FR
	Prestige Consumer Healthcare Inc NYSE:PBH	US
	Town Health International Medical Group Ltd HKEX:3886	HK

Multiples-Based Value

GSAC latest financial reports are more than 7 years old.

GSAC doesn't have a meaningful market cap.

There is not enough data to reliably calculate the multiples-based value of GSAC.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

GSAC Multiples-Based Value

Base Case

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		Gelstat Corp OTC:GSAC	1.1m USD	0	0	0	0
US		Eli Lilly and Co NYSE:LLY	883.9B USD	13.4	42.4	28.6	30.6
US		Johnson & Johnson NYSE:JNJ	585.2B USD	6.2	21.6	15	18.5
UK		AstraZeneca PLC LSE:AZN	237.5B GBP	5.4	31.2	17.2	24.2
CH		Roche Holding AG SIX:ROG	248.4B CHF	4.1	19.7	11.6	13.1
US		Merck & Co Inc NYSE:MRK	299.1B USD	4.6	16.4	10.1	12.3
CH		Novartis AG SIX:NOVN	236.4B CHF	5.4	21.8	13.5	17.3
IE	E	Endo International PLC LSE:0Y5F	244.4B USD	105.4	-83.6	386.8	970
DK		Novo Nordisk A/S CSE:NOVO B	1.1T DKK	3.4	10.3	7.6	9
US		Pfizer Inc NYSE:PFE	161B USD	2.5	20.4	7.8	10.4
US		Bristol-Myers Squibb Co NYSE:BMY	120B USD	2.5	16.9	7.1	8.8

				Revenue Growth	P/S to Growth
US		Gelstat Corp OTC:GSAC	Average P/S: 15.3 Not Available	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	13.4	19%	0.7
US		Johnson & Johnson NYSE:JNJ	6.2	7%	0.9
UK		AstraZeneca PLC LSE:AZN	5.4	N/A	N/A
CH		Roche Holding AG SIX:ROG	4.1	4%	1
US		Merck & Co Inc NYSE:MRK	4.6	5%	0.9
CH		Novartis AG SIX:NOVN	5.4	5%	1.1
IE	E	Endo International PLC LSE:0Y5F	105.4	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	3.4	1%	3.4
US		Pfizer Inc NYSE:PFE	2.5	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	2.5	-5%	N/A

				Earnings Growth	PEG
US		Gelstat Corp OTC:GSAC	Average P/E: 22.3 Not Available	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	42.4	32%	1.3
US		Johnson & Johnson NYSE:JNJ	21.6	7%	3.1
UK		AstraZeneca PLC LSE:AZN	31.2	26%	1.2
CH		Roche Holding AG SIX:ROG	19.7	14%	1.4
US		Merck & Co Inc NYSE:MRK	16.4	14%	1.2
CH		Novartis AG SIX:NOVN	21.8	14%	1.6
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -83.6	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	10.3	1%	10.3
US		Pfizer Inc NYSE:PFE	20.4	22%	0.9
US		Bristol-Myers Squibb Co NYSE:BMY	16.9	16%	1.1

				EBITDA Growth	EV/EBITDA to Growth
US		Gelstat Corp OTC:GSAC	Average EV/EBITDA: 50.6 Not Available	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	28.6	22%	1.3
US		Johnson & Johnson NYSE:JNJ	15	2%	7.5
UK		AstraZeneca PLC LSE:AZN	17.2	13%	1.3
CH		Roche Holding AG SIX:ROG	11.6	6%	1.9
US		Merck & Co Inc NYSE:MRK	10.1	3%	3.4
CH		Novartis AG SIX:NOVN	13.5	5%	2.7
IE	E	Endo International PLC LSE:0Y5F	386.8	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	7.6	1%	7.6
US		Pfizer Inc NYSE:PFE	7.8	-9%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	7.1	-10%	N/A

				EBIT Growth	EV/EBIT to Growth
US		Gelstat Corp OTC:GSAC	Average EV/EBIT: 111.4 Not Available	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	30.6	22%	1.4
US		Johnson & Johnson NYSE:JNJ	18.5	6%	3.1
UK		AstraZeneca PLC LSE:AZN	24.2	21%	1.2
CH		Roche Holding AG SIX:ROG	13.1	6%	2.2
US		Merck & Co Inc NYSE:MRK	12.3	6%	2.1
CH		Novartis AG SIX:NOVN	17.3	9%	1.9
IE	E	Endo International PLC LSE:0Y5F	970	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	9	2%	4.5
US		Pfizer Inc NYSE:PFE	10.4	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	8.8	-7%	N/A

Gelstat Corp
OTC:GSAC

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

GSAC Competitors Multiples
Gelstat Corp Competitors

See Also

Company

Help

Tools

Stocks

Gelstat Corp OTC:GSAC

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

GSAC Competitors Multiples Gelstat Corp Competitors

See Also

Company

Help

Tools

Stocks

Gelstat Corp
OTC:GSAC

GSAC Competitors Multiples
Gelstat Corp Competitors